These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6962833)

  • 1. Immunological cross-reactivities of various anthracycline antibiotics against aclacinomycin A antisera.
    Matsuzawa Y; Kiyosaki T; Yoshimoto A; Ishikura T; Takeuchi T; Umezawa H
    J Pharmacobiodyn; 1982 Nov; 5(11):886-92. PubMed ID: 6962833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for aclacinomycin A.
    Matsuzawa Y; Kiyosaki T; Oki T; Takeuchi T; Umezawa H
    Gan; 1982 Apr; 73(2):229-33. PubMed ID: 6956531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive enzyme immunoassay for the quantification of aclacinomycin A using beta-D-galactosidase as a label.
    Sohda M; Fujiwara K; Saikusa H; Kitagawa T; Nakamura N; Hara K; Tone H
    Cancer Chemother Pharmacol; 1985; 14(1):53-8. PubMed ID: 3917377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-sensitivity relationship of anthracycline antibiotics to C7-reduction by redox enzymes.
    Yoshimoto A; Tobe H; Johdo O; Ishikura T; Takeuchi T
    Jpn J Antibiot; 1991 Mar; 44(3):287-95. PubMed ID: 1908911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the stability of aclacinomycin hydrochloride. I. Stability of solution of aclacinomycin hydrochloride (author's transl)].
    Mori S; Shindo N; Miura H; Oki T; Inui T
    Jpn J Antibiot; 1980 Apr; 33(4):466-71. PubMed ID: 7411850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
    Warrell RP
    Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of aklavinone and aclacinomycins in vitro and in vivo by rhodomycin biosynthesis gene products.
    Wang Y; Niemi J; Mäntsälä P
    FEMS Microbiol Lett; 2002 Feb; 208(1):117-22. PubMed ID: 11934504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacies of aclacinomycin A by oral administration.
    Tsukagoshi S; Tsuruo T; Yamori T; Iida H; Naganuma K; Sakurai Y
    J Pharmacobiodyn; 1980 Oct; 3(10):532-6. PubMed ID: 6937651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies on aclacinomycin.
    Tone H; Nishida H; Takeuchi T; Umezawa H
    Drugs Exp Clin Res; 1985; 11(1):9-15. PubMed ID: 2424701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
    Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma kinetics of aclacinomycin A and its major metabolites in man.
    Egorin MJ; Van Echo D; Fox BM; Whitacre M; Bachur NR
    Cancer Chemother Pharmacol; 1982; 8(1):41-6. PubMed ID: 6954015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies of aclacinomycin A (ACM).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.
    Lu W; Leimkuhler C; Oberthür M; Kahne D; Walsh CT
    Biochemistry; 2004 Apr; 43(15):4548-58. PubMed ID: 15078101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of aclacinomycin-A and its metabolites effect on cell growth and macromolecular synthesis.
    Fourcade A; Farhi JJ; Bennoun M; Goldschmidt E; Tapiero H
    Biochem Pharmacol; 1983 Jun; 32(12):1819-24. PubMed ID: 6576787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of anthracycline antibiotics. I. Demethoxycarbonylation, 10-epimerization and 4-o-methylation of aclacinomycin A.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsuzawa Y; Oki T; Inui T
    J Antibiot (Tokyo); 1980 Nov; 33(11):1323-30. PubMed ID: 6941951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anthracycline antibiotics.
    Oki T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():70-84. PubMed ID: 612711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.